Retatrutide is a newly developed therapy that acts as a powerful GLP-1 receptor activator. This breakthrough approach holds significant hope for managing type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide improves insulin secretion and suppresses glucagon release, leading to improved glucose control. Clinical trials have demons